Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-16-011092
Filing Date
2016-07-14
Accepted
2016-07-14 17:09:27
Documents
3
Period of Report
2016-07-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_071416.htm 6-K 11424
2 EXHIBIT 99.1 exh_991.htm EX-99.1 19186
3 GRAPHIC logo.jpg GRAPHIC 5610
  Complete submission text file 0001171843-16-011092.txt   39471
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 161767961
SIC: 2834 Pharmaceutical Preparations